Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y- Total Holdings55 Perf Week3.20%
SponsorPortfolio Building Block ETF Type Tagsequity Return% 3Y- AUM47.71M Perf Month3.65%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter-
IndexBITA Global Pharma and Biotech Sel Indx Average Maturity Tagspharmaceutical Return% 10Y 52W High27.08 -0.39% Perf Half Y-
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low24.18 11.53% Perf YTD6.86%
Active/Passive Quant Type Tags- Flows% 1M2636.25% Volatility1.31% 0.90% Perf Year-
Dividend TTM0.02 (0.09%) ESG Type Tags- Flows% 3M2636.25% ATR (14)0.37 Perf 3Y-
Dividend Ex-DateDec 24, 2025 Dividend Type Sector/Theme Flows% YTD2636.25% RSI (14)63.57 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.13% Growth/Value SMA203.59% Flows% 3Y Rel Volume1.36 Prev Close26.33
Inverse/Leveraged Market Cap SMA505.65% Flows% 5Y Avg Volume46.44K Price26.97
IPONov 25, 2025 Option/ShortNo / No SMA2005.65% Trades Volume63,363 Change2.45%
Portfolio Building Block World Pharma And Biotech Index ETF seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index. The fund uses a "passive management" approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund's net assets in component securities that make up the index. The fund is non-diversified.